Quick Answer
Cell Source, Inc. reported Operating Income of -$4.33 million for fiscal year 2023.
Cell Source, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2023 | -$4.33M | -3.6% |
| 2022 | -$4.18M | -3.9% |
| 2021 | -$4.02M | -10.5% |
| 2020 | -$3.64M | +4.4% |
| 2019 | -$3.81M | -89.7% |
| 2018 | -$2.01M | +12.5% |
| 2017 | -$2.29M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | -$831.6K | +16.5% | +30.3% |
| June 30, 2024 | -$1.19M | -31.8% | -4.9% |
| March 31, 2024 | -$1.14M | +19.6% | -14.3% |
| September 30, 2023 | -$995.4K | +2.0% | -9.9% |
| June 30, 2023 | -$905.5K | +12.4% | +36.0% |
| March 31, 2023 | -$1.42M | -34.5% | -39.3% |
| September 30, 2022 | -$1.02M | +22.8% | +1.7% |
| June 30, 2022 | -$1.03M | -3.9% | +1.8% |
- Cell Source, Inc. showed a decrease of -3.6% in Operating Income compared to the prior fiscal year.
- Over the 2017–2023 period, Cell Source, Inc.’s operating income has declined by 88.6% (from -$2.29 million to -$4.33 million).
- The most recent figure is from Cell Source, Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on June 24, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: